(redirected from Marapuama)
Enlarge picture
muira puama

muira puama

Known as "potency wood" in Brazil. Root and bark used. Said to increase blood flow in the genitals of men and women. Bark are roots are the parts used medicinally as a tea. Overuse may result in anxiety, because it’s a stimulant. Plant grows to 15 ft (5m)
Edible Plant Guide © 2012 Markus Rothkranz
References in periodicals archive ?
The amazonian herbal marapuama attenuates cognitive impairment and neuroglial degeneration in a mouse Alzheimer model.
Riscos da associacao de Marapuama com anorexigenos em formulas para emagrecer.
Effects of Marapuama in the chronic mild stress model: further indication of antidepressant properties.
Marapuama traditionally and currently is a highly regarded sexual stimulant with a reputation as a powerful aphrodisiac.
Marapuama (Ptychopetalum olacoides) is regarded as a "brain tonic" in the Amazon region and shows a nootropic profile in rodents.
Aim of the study: Because a specific extract (POEE) of Marapuama was shown to possess promnesic and anti-amnesic properties, the aim of this study was to verify if POEE is also effective against [A[beta].sub.1-42]-induced cognitive deficit in mice.
Keywords: Acetylcholinesterase inhibitors Ptychopetalum olacoides Marapuama Cognitive deficits Neurodegenerative disorders
Ptychopetalum olacoides Bentham (Olacaceae), known as Marapuama, is a medicinal plant favored by the elderly in Amazonian communities (Elisabetsky and Siqueira 1998).
Improved endurance to particularly stressful periods is one of the medicinal claims for Marapuama (Ptychopetalum olacoides Bentham, PO), a popular Amazonian herbal.
Keywords: Ptychopetalum olacoides (Marapuama) Anti stress effects Adaptogen-like properties
Keywords: Ptychopetalum olacoides; Marapuama; Muirapuama; Antioxidant activity; Brain; Aging
Alcoholic infusions of Ptychopetalum olacoides Bentham (PO, Olacaceae), known as "muirapuama" and "marapuama", are consumed in the Amazon for the treatment of CNS-related conditions or during highly stressful periods (Elisabetsky, 1987; Grenand et al., 1987; Siqueira et al., 1998); the frequency of elders and patients recovering from pathologies associated with damage to the central nervous system (such as stroke) among its users are of particular interest (Elisabetsky and Siqueira, 1998).